SSA
PGNX

Schonfeld Strategic Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-37,918
Closed -$159K – 1394
2018
Q4 		$159K Buy
+37,918
New +$159K 0.01% 975
2016
Q4 		– Sell
-15,374
Closed -$97K – 684
2016
Q3 		$97K Buy
+15,374
New +$97K 0.02% 392